Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505531 · ClinicalTrials.gov registry record
Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 7
- Enrollment target
NCT00505531: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00505531 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00505531 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The Massachusetts General Hospital Center for Translational Pain Research is conducting a research study to see if Ultram ER, an FDA-approved pain medication, would be helpful in providing pain relief in subjects whose chronic pain is not well controlled on narcotic pain medicine.
Primary Outcome
VAS will be recorded at each visit and then analyzed
Interventions
- DRUG Benadryl
- DRUG Tramadol Extended Release Oral Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
Why NCT00505531 stopped before completion
NCT00505531 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Benadryl is the first listed.
NCT00505531 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00505531 about?
NCT00505531 is a clinical study titled "Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics". The Massachusetts General Hospital Center for Translational Pain Research is conducting a research study to see if Ultram ER, an FDA-approved pain medication, would be helpful in providing pain relief in subjects whose chronic pain is not well controlled on narcotic pain medicine.
What is the current status of trial NCT00505531?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00505531?
The interventions under investigation include: Benadryl (DRUG), Tramadol Extended Release Oral Capsule (DRUG).
Who is sponsoring clinical trial NCT00505531?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia